CAII/VII-IN-1
CAII/VII-IN-1 is an orally active hCA II (KI = 12.3 nM), and hCA VII (KI = 22.6 nM) inhibitor, showing no significant activity against hCA I. CAII/VII-IN-1 shows excellent neuroprotective activity in vivo Pilocarpine (HY-B0726A)-induced seizure model. CAII/VII-IN-1 can upregulate KCC2 and inhibit mTOR, exerting neuroprotective effects. CAII/VII-IN-1 does not show any significant neurotoxic effects or alterations in liver and kidney function. CAII/VII-IN-1 can be used for the study of epilepsy.
For research use only. We do not sell to patients.
- CAS No.: 3085155-69-4
- Formula: C27H23ClN8O5S2
- Molecular Weight:639.11
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
CAII/VII-IN-1 (Compound 16d) is safe at the given concentration in Vero cells (IC50 = 59.7 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Adult male mice (20-25 g) were injected with Pilocarpine[1].
-
Dosage:200 mg/kg
-
Administration:Orally before Pilocarpine injection
-
Result:Delayed seizures by more than twice as long as the Pilocarpine group (108.6 %).
Showed comparable efficacy in delaying seizure onset and reducing severity at most time points.
Reached 100 % survival.
Upregulated KCC2 (188.1%) and inhibited mTOR (51.39%) exert neuroprotective effects.
Chemical Information
-
CAS No. 3085155-69-4
-
Molecular Weight 639.11
-
Formula C27H23ClN8O5S2
-
SMILES
ClC1=CC=C(C=C1)C2=NN(C=C2/C=N/NC(C3=C(N(N=N3)C4=CC=C(C=C4)S(N)(=O)=O)C)=O)C5=CC=C(C=C5)S(C)(=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)